Want to become aCuraScript Customer?
CURRENT CUSTOMER?
"As a busy office manager, I don't have a lot of time to search for the right medical products. CSD not only has everything I need, I can get everything in a snap. Thanks for making my life a whole lot easier."
- Joanne SmithAnnapolis, Maryland
Take advantage of added savings opportunities . Contact your Account Manager today to learn about CuraScript SD's special offers.
The FDA is requiring all Erythropoiesis-Stimulating Agents (ESAs) to be prescribed and used under a risk management program, known as a risk evaluation and mitigation strategy (REMS).
Healthcare professionals prescribing ESAs to cancer patients must complete the ESA APPRAISE Oncology program . The ESA APPRAISE Oncology program will launch on Mar. 24th, 2010.
To learn more about where you can enroll, click here.